Stiefel Labs, a maker of dermatology and skin-care products, was bought out by GlaxoSmithKline in July of this year. GSK announced on wednesday that it plans to shut down the New York laboratory and move the work from there to other domestic and international locations. The plant employs 260 people who will be [...]
Continue reading...Friday, October 9, 2009
Stiefel Laboratories Inc. is moving it’s Atlanta operation to North Carolina’s Research Triangle Park. This move comes months after Stiefel was bought out by UK’s GlaxoSmithKline. 200 Atlanta jobs will be lost, with no word yet on how many jobs will end up in North Carolina. GlaxoSmithKline purchased Stiefel Laboratories, a global leader in [...]
Continue reading...Thursday, June 4, 2009
Drugmaker Adolor will eliminate 45 jobs to cut costs by $12 million. The firm will focus on its constipation drug Entereg, its only approved product, and its late-stage products, and cut early-stage drug development. Adolor markets Entereg through a partnership with GlaxoSmithKline. Exton, Pennsylvania’s Adolor Corporation is a biopharmaceutical company specializing in the discovery, development and commercialization of [...]
Continue reading...Thursday, February 5, 2009
As we reported, British drug maker GlaxoSmithKline PLC will cut jobs and costs after Q4 net profit fell 10%, the firm confirmed today. The company, which sells asthma treatment Advair and the Ribena range of soft drinks, booked a net profit of £1 billion ($1.46 billion). Sales rose to £6.91 billion from £5.97 billion a year earlier, [...]
Continue reading...Sunday, February 1, 2009
UK pharmaceutical company GlaxoSmithKline will announce about 6,000 job losses when it posts results this week, the Sunday Telegraph newspaper reports. The cuts by Glaxo, the world’s second largest drug company after Pfizer, are part of CEO Andrew Witty’s strategy to meet increased competition from generic drug makers. The company, which employs about 100,000 people globally, has [...]
Continue reading...
Thursday, November 12, 2009
1 Comment